Browsing: gene

Investing.com — Sangamo Therapeutics Inc (NASDAQ:) announced on Monday that Pfizer (NYSE:) has ended their partnership to co-develop a gene…

By Deena Beasley LOS ANGELES (Reuters) – Student Zoe Davis, 20, was just weeks into her junior year when she…

The biotechnology sector is witnessing a paradigm shift as gene editing emerges as a transformative force in medicine. CRISPR Therapeutics…

The Food and Drug Administration on Friday approved Pfizer’s treatment for a rare genetic bleeding disorder, making it the company’s…